The Covid-19 vaccine developed by BioNTech SE in partnership with Pfizer Inc received a conditional marketing authorisation in the EU on 21 December – only hours after having been given a positive opinion by the European Medicines Agency. ---Subscribe to MedNous to access this article--- Company News Regulation & Policy
